Videos
Industry-Sponsored Lecture (GSK)
COVID and AMR: Antibiotic Use During COVID-19 Pandemic and Implication for the Future
Speaker: Adrian Lijavetzki, MD
Videos
Industry-Sponsored Lecture (Camber)
Clinical Advances in the management of HIV guidelines and New Evidence
Speaker: Joseph Perriëns, MD, PhD
University of Ghent, Belgium
Videos
Industry-Sponsored Lecture (Roche)
Understanding COVID-19: Testing and Optimizing Testing Strategies
Speaker: Aw Tar Choon, MD
Videos
Industry-Sponsored Lecture (Pfizer)
Clinicians insights in the Management of Severe CAP, HAP and VAP
Speaker: Albert Rafanan, MD, FPCP, FPCCP
Videos
Industry-Sponsored Lecture (Roche)
ONE AND DONE: Reducing the Burden of Adult Influenza through a New Antiviral Treatment with a Novel Mechanism of Action
Speaker: Dominic Dwyer, MD
Videos
Industry-Sponsored Lecture (Pfizer)
Ceftaroline in Combating Community-Acquired Pneumonia (CAP)
Speaker: Alex Soriano, MD
Head of Infectious Diseases Department, Hospital Clinic
Assistant Professor, University of Barcelona
Clinical Practice Guidelines
Patients undergoing regular hemodialysis are considered vulnerable and thus require specific guidelines in the context of COVID-19. The goal is to minimize the risk of transmission of SARS-CoV-2 in facilities that provide routine hemodialysis services to this specific group of immunocompromised individuals. This document will guide nephrologists, physicians and other healthcare professionals practicing in hemodialysis units as they attend to patients seeking hemodialysis services in their facilities. Recommendations in this rapid guidance are based on best available evidence and will be updated as new evidence becomes available.
You may download a copy of the PSN-PSMID-PHICS Interim Guidelines in the Prevention and Control of COVID19 Infection in Hemodialysis Facilities here.
Info-graphics
Videos
Dr. Cynthia Saloma of the Philippine Genome Center explains the difference of SARS-CoV-2 and the new UK Strain Variant. (Source: Department of Health)
Videos
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.
